Atlas Trials

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

Clinical trial NCT02979470 · UNKNOWN

Trial details

NCT number
NCT02979470
Sponsor
AC Camargo Cancer Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Colon Cancer Stage IIbRectum Cancer, AdenocarcinomaColon Cancer Stage IIIaColon Cancer Stage IIIcColon Cancer Stage IIIb
Start date
2016-09-01
Primary completion
2018-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.